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T  lymphocytes  are responsible for regulatory control of both cellular and humoral 
immune  responses  (1, 2), Studies  from  many  laboratories have  demonstrated  the 
importance of  the murine H-2 complex, particularly the  I region, in these activities  of  T 
cells  (3).  Tada and co-workers (4, 5) and Murphy et al. (6) have defined the crucial  role 
of the I-J subregion  in various  aspects of T-cell-mediated  suppression.  In addition, 
Debrd et al. (7) have demonstrated the importance of  two complementing genes mapping 
in the  ]-A or  ]-B and ]-C subregions in determining suppressor T-cell  (T~)  I  responses. 
In addition, it has become apparent that soluble materials either secreted by T cells 
in  culture (8)  or  obtained from T cells  after  mechanical disruption can mediate suppressor 
function. Tada  and  associates (9, 10) and  this laboratory  (11) have  described  the 
presence of soluble materials with antigen-specific suppressive  activity  in sonicates of 
suppressor T  lymphocytes  specific  for protein antigens and for synthetic polypeptide 
antigens, respectively. 
The soluble T cell-derived  suppressor factors  (T~F)  obtained from genetic nonresponder 
mice  challenged  with  L-glutamic  acid~°-L-alanine~°-L-tyrosine  I° (GAT)  or L-glutamic 
acidS°-L-tyrosine  5° (GT) have been extensively characterized  (12-15).  The GAT-T,F  has 
been shown to be at least partially  protein in nature, to possess a molecular weight of 
approximately 45,000, to display binding specificity  for GAT,  and to possess/-region, 
but not conventional  immunoglobulin  determinants.  In addition, the crude  TsF  is 
bound by a rabbit anti-GAT immunoadsorbent,  indicating the presence of  a fragment of 
GAT  in the  suppressive  complex.  GAT-TsF  binds  to  a  GAT-Sepharose  adsorbent 
(Pharmacia Fine Chemicals, Piscataway, N. J.),  and can be eluted with 2 M  KCI or 
with pH 2.5 acid glycine buffer. This purified GAT-TsF no longer binds to rabbit anti- 
* Supported by grant AI-09920 from the National Institute  of  Allergy and Infectious  Disease 
and grant CA-09130 from the National Cancer Institute. 
Present address:  Institute  Pasteur,  Paris,  France. 
§  Present address:  The Jewish Hospital  of  St. Louis,  St. Louis,  Missouri  63110. 
~Abbreviations  used  in  this paper:  C,  complement;  GAT,  random terpolymer L-glutamic 
acid6°-L-alanine3°-L-tyrosine~°;  GAT-MBSA, GAT complexed to methylated bovine serum albumin; 
GT, random copolymer L-glutamic acidS°-L-tyrosineS°; i.p.,  intraperitoneally; i.v., intravenously; 
Hepes, N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid; KLH, keyhole limpet hemocyanin; 
MDH, modified Mishell-Dutton  medium containing Hepes; OVA, ovalbumin; PFC, plaque-forming 
cell(s); $5o, inverse dilution of TBF needed to give 50% suppression  of GAT-MBSA responses  in 
vitro;  SRBC, sheep erythrocytes; TNP~-OVA, trinitrophenylated ovalbumin;  TB, suppressor T 
lymphocyte(s); TsF, T-lymphocyte-derived  suppressor factor (extract). 
THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  •  VOLUME  147, 1978  123 124  INDUCTION  OF  SUPPRESSOR  T  CELLS  IN  VITRO 
GAT-Sepharose,  demonstrating  that  the  serologically detectable  GAT fragment(s)  is 
(are) lost during such purification. The GT-TsF prepared from H-2  k mice can be bound 
by  an  anti-I-J  k  Sepharose  adsorbent,  confirming for  the  polypeptide-specific TsF  the 
presence  of I-J  determinants  reported  by  Tada  et  al.  to  be  on  protein-specific T~F. 
Studies by Waltenbaugh et al. (16) on the mechanism of action of crude T~F preparations 
demonstrated  that  in  vivo  administration  of GT-T~F  or  GAT-T~F  to  naive  animals 
induces  antigen-specific suppressor T  cells in  such  recipients.  This  finding  suggested 
that  an  important  function  of  these  T  cell-derived  antigen-specific  factors  is  the 
stimulation of a  second set of specific T  cells to become the effector suppressor T  cells 
actually  responsible  for  inhibition  of  immune  responses.  In  agreement  with  these 
findings, Tada (17) reported that the specific TsF studied in his laboratory was produced 
by Ly 2,3+  cells and stimulated the generation of T~. 
The earlier finding that  GAT-TsF in the crude extract was complexed to GAT 
or a  GAT fragment  raised the possibility that both GAT-TsF and antigen  might 
be  required  for  efficient  induction  of GAT-Ts  in  this  model.  To  resolve  this 
issue and better understand  the precise nature  and interactions of the cells and 
factors  involved  in  T-cell-mediated  antigen-specific  suppression,  an  in  vitro 
system  was  designed  for  inducing  Ts  under  defined  conditions.  The  current 
study focuses on the production of Ts by GAT-T~F. The data demonstrate  that 
GAT-T~F does indeed induce normal  spleen cells to develop antigen-specific T~ 
in vitro, and that both H-2 determinant-bearing  TsF and a  small amount  of the 
GAT antigen  itself are necessary for this Ts induction. 
Materials  and  Methods 
Mice.  DBA/1  (H-2  q) mice were purchased from The Jackson Laboratory (Bar Harbor, Me.). 
Mice were maintained on laboratory chow and acidified-chlorinated water ad lib., and used at 
10-16  wk of age.  Animals were  always rested for 7-14  days after receipt before inclusion in 
experiments, and were sex- and age-matched in any single experiment. 
Antigens.  GAT,  -50,000  tool  wt  (lot  VI),  was  purchased  from  Miles  Laboratories  Inc. 
(Elkhart,  Ind.).  Methylated bovine  serum  albumin  (MBSA)  was  obtained from  Worthington 
Biochemical Corp.  (Freehold, N.  J.)  and  GAT-MBSA complexes,  sheep  erythrocytes (SRBC; 
GIBCO,  Grand Island, N.  Y.),  and  GAT were prepared for use as previously described (18). 
Ovalbumin (OVA; Miles Laboratories) was trinitrophenylated by reacting the protein, at 10 mg/ 
ml  in  0.5% sodium  carbonate,  with  picryl chloride  (Nutritional  Biochemicals  Corporation, 
Cleveland, Ohio) equal to 5% of the total protein weight for 2 h at room temperature, followed by 
exhaustive dialysis against phosphate-buffered saline. The preparation used in these studies 
contained approximately 6 trinitrophenyl groups per OVA molecule (TNP~OVA). 
Preparation and Immunoabsorbent Purification of Cell-Free Extracts.  Cell-free extracts were 
prepared as previously reported  (13). Briefly, DBA/1  mice were  inoculated intraperitoneally 
(i.p.) with Maalox (William H. Rorer Inc., Fort Washington, Pa.) alone or with 10 jzg GAT in 
Maalox. 3-7 days later, cell suspensions were prepared from thymus and spleen. The cells were 
sonicated at 50-60 W for 5 rain at 4°C, and the lysate centrifuged at 40,000 g  at 4°C for 1 h. The 
supernates (Maalox [control] extract or crude GAT-T~F, respectively) were collected and stored 
at  -80°C  until use.  Purified GAT-TsF was  prepared by 2  M  KC1  elution of the suppressive 
material bound to a  GAT-Sepharose column followed by gel filtration to remove excess salt, as 
reported previously (13). 
The  presence  of H-2  determinants  in  the  active extracts  was  assessed by passage  of the 
suppressive  material  over  Sepharose  immunoabsorbents  prepared  with  the  immunoglobulin 
fraction of heat-inactivated specific alloantisera, as described (13). The antisera used in these 
studies  were  obtained from Dr.  Martin  E.  Dorf (Department of Pathology, Harvard  Medical 
School) and consisted of anti-H-2  b serum: (DBA/1  × DBA/2)Fz anti-D1.LP, and anti-KqIq serum: 
(DBA/2  x  B10.BR)F1  anti-B10.T(6R),  raised  by  repeated  inoculation  with  lymphoid  cells, 
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In Vitro Assay of GAT-T,F.  The direct suppressive activity of Maalox extract or of the crude 
and purified GAT-TaF was assayed by a  modification of the previously reported Mishell-Dutton 
culture system (18, 19). In brief, replicate 1-ml cultures of 7.5  x  l0  s viable DBA/1 spleen cells in 
Mishell-Dutton  medium  plus  10  mM  N-2-hydroxyethylpiperazine-N'-2-ethane  sulfonic  acid 
(Hepes; MDH) were established in the 16-ram wells of a  24-sample multiwell dish (Linbro FB-16- 
24TC; Linbro Chemical Co., New Haven, Conn.). Cultures contained either no extract or various 
dilutions (1/400-1/51,200) of Maalox extract or GAT-TsF, and either 1 pg GAT as GAT-MBSA or 
2  x  10  e SRBC. The cultures were incubated at 37°C with rocking in 7% 03, 10% CO~, 83% N2, and 
the  GAT or  SRBC  plaque-forming cell  (PFC)  responses  measured 5  days  later,  as  previously 
described (18).  Results are expressed as IgG GAT-PFC per culture of 7.5  x  10  e cells. 
In Vitro Induction and in Vivo Assay of GAT-T,.  Single cell suspensions of washed DBA/1 
spleen cells were prepared in MDH at 20 x  106/ml. 1.5 ml of this cell suspension was mixed in 60- 
mm tissue culture Petri dishes (Falcon Plastics, Oxnard,  Calif.) with 1.5 ml of MDH containing 
either no additions, various amounts of GAT, or various dilutions of Maalox extract or crude or 
purified GAT-T~F. These cultures were incubated at 37°C  with rocking in 7% O2,  10% CO~,  83% 
N2 for 2 days,  then washed four times by centrifugation and resuspended in serum-free Hanks' 
balanced salt solution at 6  x  10  e viable cells/ml. DBA/1 mice then received 0.5 ml of the washed 
cell  suspensions  containing 3  x  10  e  viable  cells  intravenously  (i.v.),  followed  within  1  h  by 
immunization i.p.  with the appropriate antigen.  PFC per spleen were determined 7 days later 
with unmodified SRBC,  GAT-SRBC, or TNP-horse erythrocytes (20). 
Treatment with Anti-Thy 1.2.  T  lymphocytes were  removed from cell suspensions after T s 
induction and before transfer in vivo by treatment with anti-Thy  1.2 plus complement  (C)  as 
previously described (21).  Briefly, 50 x  107 cultured cells were mixed with 0.2 ml of anti-Thy 1.2 
(AKR anti-C3H) or normal mouse serum diluted 1:5 with Eagle's Minimum Essential Medium 
containing 10 mM N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (Hepes) and 10%  heat- 
inactivated fetal calf serum,  incubated 30 rain at 4°C,  washed once and resuspended in selected 
rabbit serum diluted  1:5 as a  complement source.  After 45 rain at 37°C,  the cells were washed 
three  times  with  serum-free  Hanks'  balanced  salt  solution  and  resuspended  to  a  volume 
calculated to give 6  x  106 cells/ml before treatment. 0.5 ml of treated cell suspension was then 
given i.v. to each mouse, followed by immunization with antigen. 
Preparation  and Use of Purified T Cells.  T cells were partially purified from normal DBA/1 
spleen cells by passage over nylon wool, essentially as described by Julius et al.  (22).  Such "T- 
cell" preparations contained less than 5% surface immunoglobulin positive cells, as assessed by 
fluorescence microscopy. These T cells were then cultured as described above for induction of T8 
after addition to culture dishes containing Maalox extract or GAT-T,F and X.irradiated  (1,500 
R) splenic adherent cells from 30  x  106 spleen cells to replace the macrophages lost by nylon 
wool passage. 
Immunization.  Mice  were  immunized  i.p.  with  0.2  ml  of  10%  washed  SRBC  in  Hanks' 
solution, or either 10/zg of GAT as GAT-MBSA or 200/~g of TNP~OVA in Maalox plus 2  x  109 
pertussis organisms (Eli Lilly & Company, Indianapolis, Ind.). 
Results 
Induction  of  Suppressive  Activity  in  Spleen  Cells  Cultured  in  GAT- 
T,F.  Previous studies with GT-TsF demonstrated that the i.v.  inoculation of 
even  greatly  diluted  GT-TsF  preparations  caused  long-lasting  suppression  of 
GT-MBSA PFC responses, and that this suppression could be transferred with 
Thy 1.2 positive cells (16). These data indicated that GT-TsF was able to induce 
GT-specific Ts in vivo. In vivo induction  with GAT-TsF of specific T s has also 
been demonstrated. A similar ability for GAT-TsF to stimulate the development 
of GAT-Ts can be demonstrated in vitro, as shown in Fig. 1. Transfer of 3  ×  10  s 
syngeneic spleen cells incubated with  1/200 or 1/400 dilutions of crude  DBA/1 
GAT-TsF for 2 days completely suppressed the  subsequent GAT-specific PFC 
response to GAT-MBSA in DBA/1 mice. Cultivation of spleen cells with a  1/600 
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FIG.  1.  Ability of various concentrations of DBA/1 GAT-TsF to induce suppressive activity 
in DBA/1  spleen cells in vitro.  DBA]I  spleen cells were incubated with the given final 
concentrations of GAT-TsF or control extract (6  ×  10  8 cell equivalents/ml =  undiluted) as 
described in Materials and Methods, harvested 2 days later, and washed. 3  ×  10  e viable 
recovered cells were transferred i.v. to each recipient, each of which then received 10  ~g 
GAT as GAT-MBSA in Maalox with pertussis vaccine. IgG GAT-specific PFC per spleen 
were determined 7 days later. P  values calculated by Student's t test. 
1/800  GAT-TsF  was  ineffective  at  the  3  x  106  cell  dose  transferred  in  this 
experiment.  The $50 (inverse dilution of TsF needed to give 50% suppression of 
GAT-MBSA responses in vitro) of the GAT-TsF used for these experiments was 
found to be  1,000-1,200,  and  thus,  only slightly  greater  (<twofold) than  the 
suppressor  induction  activity  assayed here  under  quite  different  conditions. 
Control  (Maalox) extracts did not induce suppressor cells under similar condi- 
tions;  in  fact,  in  several  experiments  mice  receiving  cells  incubated  with 
control  extracts  gave  slightly  higher  responses than  mice  receiving  no  cells 
(data not shown).  In other experiments,  the number of cells needed to obtain 
50% suppression after induction with 1/200 GAT-TsF ranged from 3 x  10  s to 1 x 
106, with 2-3  x  10  s cells always giving >85% suppression. Hence, 3  x  10  s cells 
and 1/200 GAT-TsF were chosen for all subsequent experiments. 
Evidence That the Active Suppressor Cell Induced by GAT-T,F is a T Cell.  To 
establish that the suppression of the GAT-MBSA response seen after transfer 
of spleen cells incubated with GAT-T~F was indeed due to T  lymphocytes, as 
predicted  by analogy  with the  in vivo GT-T~F  studies,  two approaches  were 
used.  In  the  first,  spleen  cells  cultured  in  1/200  GAT-TsF  for  2  days  were 
treated with anti-Thy 1.2 plus C before transfer,  and their residual suppressive 
activity measured.  Fig.  2 presents  data  from a  representative  experiment  of 
this  type.  Spleen  cells  incubated  in  control  extract  were  not  suppressive, 
whereas cells incubated in 1/200  GAT-TsF caused complete suppression of the 
GAT-MBSA response. Transfer of cells after anti-Thy 1.2 plus C treatment did 
not cause a  detectable suppression.  In several other similar experiments,  the 
same elimination of suppressor cell activity was seen with a different prepara- 
tion of anti-Thy 1.2 serum, and no reduction in suppression seen after treatment 
with C  alone or C  plus normal  mouse serum  (data not shown).  Table I  gives R.  N.  GERMAIN,  J.  THEZE,  J.  A.  KAPP,  AND  B.  BENACERRAF  127 
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FIo. 2.  Sensitivity  of  in vitro  GAT-T,F-induced suppressor  cells  to  treatment  with  anti- 
Thy 1.2 plus  C. Same protocol  as for Fig. 1, except  that some cells  were treated  as 
described  in Materials  and Methods with anti-Thy  1.2  plus  C before  transfer. 
TABLE  I 
Induction of GAT-Specific T, in Vitro using Purified T Cells and Crude GAT-T,F 
Cells trans-  IgG GAT-specific  p  Valu~l 
Culture*  ferred$  PFC/spleen§ 
None  None  2,456 ±  503  - 
1f200 Maalox extract and whole spleen  3 x  l0  s 
1t200 Crude GAT-T,F and whole spleen  3 x  10  e 
1/200 Maalox extract and purified T cells¶  2 ×  106 
1/200 Crude GAT-TsF and purified T cells  2 x  10  e 
2,006  ±  659  0.607 
413  ±  155  0.008 
1,893  ±  192  0.336 
450  ±  137  0.008 
* See Materials  and Methods. 
Number of  viable  cells  after  culture  transferred i.v.  per  recipient. 
§  Mean IgG GAT-specific PFC per spleen ±  SEM  detected 7 days after  cell  transfer  arid 
immunization with  10 ~g GAT as GAT-MBSA in Maalox with  pertussis  vaccine. 
I[  Calculated  by Student's  t  test.  Comparison to  group  receiving  no transferred  cells. 
¶ Nylon wool-passed  cells  with <5% B cells  and irradiated  splenic  adherent  cells. 
data from a second type of experiment,  establishing the T-cell dependence  of 
the observed  suppression  of the GAT-MBSA  response.  Nylon  wool column- 
passed cells  containing  <5%  B  cells  were incubated with 1/200 GAT-TsF  or 
control extract for 2 days, then 2 x 106 cells  were transferred and the recipients 
challenged with GAT-MBSA.  The purified T cells  cultured with GAT-TsF gave 
the same complete suppression of  the GAT-MBSA  response as seen when  3 × 
106 GAT-T~F cultured whole spleen cells  were transferred. Taken together, the 
anti-Thy 1.2 and nylon wool purification experiments are strong evidence that 
the suppression of  the GAT-MBSA  response seen after transfer of spleen cells 
incubated with GAT-T~F is due to T lymphocytes. 
Antigen Specificity of Suppression  Mediated by GAT-T,F-Induced Suppres- 
sor T Cells.  Although  T s cells and TsF  in the  GAT-GT  systems have  always 
proved to  be  antigen  specific,  reports  of nonspecific  T  suppressor  cells  (2,  23) 
make  necessary documentation  of the specificity of the T~ induced by GAT-Ts  F. 
Fig.  3  demonstrates  that  transfer  of 3  ×  10  s  Ts  induced  by  1/200  GAT-Ts  F  is 128  INDUCTION  OF  SUPPRESSOR  T  CELLS  IN  VITRO 
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Fro.  3.  Antigen specificity of in vitro GAT-TsF induced suppressor T cells. Same protocol 
as Fig.  1,  except some groups challenged with 0.2 ml 10% SRBC in Hanks' balanced salt 
solution or 200 ~g TNP~OVA  in Maalox with pertussis vaccine, and assayed on SRBC or 
TNP-horse erythrocytes, respectively. 
able to selectively suppress the IgG GAT-specific PFC response to GAT-MBSA 
and not the IgG SRBC or IgM TNP~-OVA  response. Some decrease in the IgG 
TNPvOVA  response  is  observed  upon transfer of DBA/1  cells cultured with 
control extract or GAT-TsF, but no differences in the effects of cells incubated 
with these two materials were found, in contrast to their quite distinct effects 
on  the  GAT-MBSA  response.  Although  the  cause  of this  mild  nonspecific 
suppression is not known at present, the data clearly reveal the GAT-specific 
activity of the GAT-TsF-induced Ts in this system. 
The GAT-T,F Which Stimulates the Development of T, Bears H-2 (K and/or I) 
Determinants.  Characterization of antigen-specific TsF revealed the presence 
of H-2, and more specifically, I-J determinants on the active material (13, 15). 
To  ascertain  whether  such H-2  determinants  were  present  on  the  moiety 
responsible  for T  s induction by TsF,  GAT-TsF  from DBA/1  (H-2q) mice  was 
passed over an anti-H-2  b or anti-KqI  q Sepharose immunoadsorbent. The mate- 
rial that passed through the column was tested for induction of Ts in vitro. The 
data from one such experiment are presented in Fig. 4. As can be seen,  1/200 
GAT-TsF induces active T,, as does 1/200 GAT-T~F passed over a  control anti- 
H-2 b immunoadsorbent.  However,  the  ability to  induce T~  is  removed  from 
GAT-TsF by passage  over  an  anti-KQI  q column,  indicating that  at  least one 
component necessary for stimulation of T~  bears  K q and/or Iq  determinants, 
and thus is identical to previously studied TsF in this regard. 
Role  of Antigen  in  the  Induction  of T,  in  Vitro  by  GAT-T,F.  It  was 
previously  demonstrated  (13) that  the  material  in  crude  GAT-T~F  able  to 
suppress GAT-MBSA responses could be removed by a rabbit anti-GAT Sepha- 
rose column, implying that GAT was complexed to the suppressive moiety. It 
was also shown that crude GAT-TsF bound to and could be eluted from a GAT- 
Sepharose  adsorbent.  Furthermore,  column-purified  GAT-T~F  retained  full 
suppressive activity upon direct in vitro testing in the presence of GAT-MBSA. 
Further  studies  revealed  that  the  purified  GAT-T~F  recovered  from  such  a R.  N.  GERMAIN,  J.  TH~.ZE,  J.  A.  KAPP,  AND  B.  BENACERRAF 
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FIG.  4.  Presence of H-2-K~I" determinants on active material in GAT-T,F able to induce 
T, in vitro.  Same protocol as Fig. I except portions of GAT-T,F were passed through anti- 
H-2  b or anti-H-2K~I~ Sepharose immunoadsorbents  before use in T, induction. 
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FIG. 5.  Induction of T, in vitro by GAT. The given total amounts of GAT were added to 3- 
ml cultures of DBA/1 spleen  cells containing 30  x  106 cells. 2 days later, the cells were 
recovered  and  washed,  and  3  x  106  transferred  per recipient.  These  mice  were  then 
challenged  with  10  ~g GAT as GAT-MBSA in  Maalox with pertussis vaccine,  and IgG 
GAT-specific PFC per spleen measured 7 days later. 
GAT-Sepharose column lacked the serologically detectable piece of GAT. These 
findings raised the issue of whether GAT-T ,F needs to be bound to GAT for the 
efficient  stimulation  of  GAT-specific  suppressor  T  cells.  As  a  first  step  in 
answering  this  question,  free  native  GAT,  known  to  induce  GAT-T, in  vivo, 
was tested for T6 induction  in vitro.  Fig.  5 reveals that spleen cells incubated 
with  1-5 ~zg of GAT per culture  (0.33-1.67  ~g/ml) developed GAT-T6 that were 
capable of complete suppression of the GAT-MBSA response when 3  x  106 cells 
were transferred per recipient.  Spleen cells cultured with 50 ng GAT were not 
significantly  suppressive  under  these  conditions.  These  data  are  consistent 
with earlier work on direct suppression of DBA/1  responses in  culture by free 
GAT, in which  >0.1  ~g/ml was found necessary for elimination of GAT-MBSA 
PFC  responses  (24).  They also indicate  that the  amount  of GAT in  the  crude 
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FIo.  6.  Direct in vitro suppression of the GAT-MBSA responses mediated by crude or 
purified  GAT-T,F.  Cultures  containing the  indicated final  concentrations of crude  or 
purified GAT-T,F or control extracts were established and assayed on day 5 as described in 
Materials and Methods. No significant effects on SRBC responses were seen, and these 
data are omitted for clarity. Panels A and B represent separate experiments. 
induction in vitro, because 1/200 dilutions of the crude extracts would contain a 
maximum of 100 ng of GAT if all the antigen  injected in the mice from which 
the GAT-T=F  was prepared were recovered in the extract. This is consistent as 
well  with  the  requirement  for  an  H-2  coded  product  for  the  induction  of 
suppressor cells. 
Fig.  6  shows the  results  of titrations  of the  crude  GAT-TsF  used  in  these 
studies and of two different preparations of purified GAT-T=F directly on the in 
vitro PFC response of DBA/1 spleen cells to GAT-MBSA. None of the extracts 
suppressed the control SRBC responses at any concentration  tested  (data not 
shown).  Control  (Maalox) extracts  had  no effect or slightly suppressed  GAT- 
MBSA responses at the highest concentration  tested,  and had either no effect 
or enhanced  GAT-MBSA responses  at greater  dilutions.  The  crude  GAT-TsF 
had an $50 of between 1,000-1,600 on repeated testing, whereas the two purified 
GAT-T=F  had  $50  of between  10,000-16,000,  10-fold  higher  than  the  crude 
material  from  which  they  were  derived.  This  increase  was  due  in  part  to 
concentration  of  the  material  during  column  purification  (fivefold)  and  a 
repeatedly  observed  increase  in  suppressive  activity  of purified  material  of 
about twofold,  probably due to  the  removal  of nonspecific culture-enhancing 
materials which partially mask the suppressive activity of crude extracts  (13). 
The two purified GAT-TsF preparations were then tested for induction of 'Is 
in  vitro  in  the  absence  of  added  antigen.  Fig.  7A  presents  data  for  one 
preparation  of purified  GAT-TsF,  and 7 B  for the second,  with the data taken 
from one of three  or four replicate experiments.  The crude GAT-TsF at  1/200 
final dilution clearly induced 'Is capable of suppressing the GAT-MBSA response 
in each experiment.  The purified materials were used as 1/200 dilution of the 
concentrated,  10-fold more active material  and  yet both failed to induce  any 
significant  'Is  activity.  10  or  50  ng  of  GAT  alone  yielded  no  significant R.  N.  GERMAIN,  J.  THEZE,  J.  A.  KAPP,  AND  B.  BENACERRAF  131 
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FIG.  7.  Requirement  for both  purified  GAT-T,F and  GAT  for in vitro GAT-specific T s 
induction.  Protocol is essentially  identical to  Figs.  1 and  5.  Panels  A  and  B  represent 
separate experiments with different preparations of purified GAT-T,F. 
suppression, as expected. However, cells incubated with both low doses of GAT 
and  purified  GAT-TsF  demonstrated almost  complete  suppression  of GAT- 
MBSA responses upon transfer. Thus, these data indicate that for induction of 
GAT-specific  Ts  in  vitro  by  GAT-TsF,  both  an  H-2  coded  antigen-specific 
material and a small amount of GAT are required. 
Discussion 
The activity of both crude and purified soluble GAT-suppressive extracts was 
investigated by a combination of in vitro and in vivo techniques. In agreement 
with earlier in vivo studies on the mechanism of action of GT-TsF and GAT-TsF 
by Waltenbaugh et al. (16), we have shown that addition of low concentrations 
of GAT-TsF to cultures of syngeneic spleen cells stimulates the development of 
GAT-Ts which after transfer are able to suppress the GAT-MBSA response of 
recipient mice. The cells responsible for this suppression were shown to be T 
lymphecytes, both by using purified T  cells for suppressor-cell induction in 
vitro and by elimination of suppressive activity of cells cultured with GAT-T~F 
by treatment with anti-Thy 1.2  plus  C before cell transfer. The suppression 
was  demonstrated to  be  antigen specific with both  particulate  (SRBC)  and 
soluble  (TNP-OVA)  control antigens. For the induction of GAT-Ts, a  moiety 
bearing H-2 (K  q and/or I  q) determinants and also GAT itself,  either  bound to 
the crude GAT-TsF or added in nanogram  amounts to antigen-free purified 
T~F, were both required.  Purified  GAT-T~F, which lacks  detectable  GAT, was 
shown to  be suppressive when tested  directly  on spleen cell  cultures  containing 
GAT-MBSA  (Fig.  6), but not to be able to induce T~ in the absence of added 
GAT  (Fig.  7). This suggests that the GAT-MBSA  provides the requisite  GAT 
antigen  in the assay cultures for induction by purified GAT-T~F  of GAT- 
specific T~ which in turn suppress the GAT-MBSA response. 132  INDUCTION  OF  SUPPRESSOR  T  CELLS  IN  VITRO 
These results  extend earlier  observations on the ability  of  extracts  of  T-cell 
preparations containing suppressor T lymphocytes to interfere  with immune 
responses.  Several laboratories  have reported  on such  TsF.  Tada et  al.  originally 
demonstrated that mice receiving two injections  of soluble protein antigen, 
such as keyhole limpet hemocyanin  (KLH) had Ts and could yield T~F with 
properties of antigen specificity,  size,  and the presence of la determinants 
similar to those  recently  described for the GAT- and GT-TsF (9, 10, 25).  They 
did not, however,  describe any antigen  to be present in their active TsF 
materials, in contrast  with crude GAT-T~F. The KLH  TsF described by Tada 
also appears to induce certain antigen-primed  T cells  to become mature T  s 
in the presence of added KLH  (17).  This resembles the results  reported here, 
and careful analysis of the material necessary  for this effect may  reveal 
whether both antigen and/-coded factor  are always necessary for  the induction 
of  suppressor T cells  by TsF. In this  regard, it is important to determine the 
reason for the discrepancy between the strict  I-J matching required for KLH- 
TsF activity  (4)  and the lack  of  such restrictions  reported  for GAT- and GT-T~F 
(12, 14).  The possibility  that the presence of  antigen in the latter  TsF prepara- 
tions may mask inherent I-J restrictions  must be considered. Also, because 
KLH-T~F is assayed with secondary responses whereas GAT-TsF is assayed on 
primary responses, it is possible  that the l-J restriction  is a result of the 
primed state  of  the target  T cells  in the KLH  model. 
The present experiments do  not establish  definitively  that  the active  material 
in the GAT-T~F responsible  for  T~ induction has both la (more particularly  I-J) 
determinants and antigen-binding activity  in the same molecular complex, as 
was shown for GT-TsF responsible  for direct  in vitro  suppression (15).  Purified 
GT-Ts  F eluted  sequentially  from GT-Sepharose and anti-l-J  Sepharose is now 
being tested  for  Ts induction  to answer this  precise  question and also  to  test  for 
the requirement for additional  GT antigen, to confirm the findings  for  purified 
GAT-TsF reported here. The ability  of GAT-TsF and GT-TsF to act across  H-2 
barriers  in  T~ induction  is  being examined with preliminary data suggesting no 
absolute requirements  for either immune  response  gene or I-J subregion 
matching (R. N. Germain, unpublished observations). 
Several other soluble T-cell-derived  suppressor substances have been de- 
scribed  (26-29). One of these is  a  suppressive supernate from T~-containing 
spleen cells in the allotype suppression model studied by Herzenberg et al. 
(30). This factor is not antigen-specific, but seems to directly inactivate allotype- 
specific  helper T cells without the induction of allotype-specific Ts.  It is thus 
clearly distinct  in  effect from  the  KLH-  or  GAT-T~F.  Whether  a  similar 
material active directly on helper T cells is present in extracts from antigen-, 
as  opposed  to  allotype-suppressed  mice  is  not  yet  known,  but  might  be 
postulated to be the product of the T~ induced by the GAT-TsF studied here. 
The  ability  of  GAT-T~F to  induce  GAT-specific  Ts  raises  several  other 
questions  concerning the  pathways  of cellular  and  soluble  factor  activity 
responsible  for  T  lymphocyte-dependent suppression.  The  studies  of Debr$ 
et al.  (31) have shown that mice which normally produce Ts in response to GT 
fail to do so after cyclophosphamide pretreatment. However, such mice and A/J 
mice (which have a genetic inability to be suppressed by GT) can be suppressed 
by GT-T~F (14, 31). Taken together with the data in this paper, it would seem R.  N.  GERMAIN,  J.  THEZE,  J.  A.  KAPP,  AND  B.  BENACERRAF  133 
that at least two distinct T cells are involved in immune suppression, one of 
which produces TsF in response to antigen, and the second of which is activated 
by this TsF plus antigen to become the effector Ts. The experiments of Feldman 
and co-workers on T1-T2 cell interaction in suppression  (32), and Ly and Ia 
phenotyping of Ts (33), support this concept. In addition, this two-cell model of 
producer and acceptor cells superficially resembles that described by Munro 
and Taussig (34) for factor production by T helper cells and factor acceptance 
by B cells. The existence of distinct Ir gene defects at these two sites has been 
documented in the branched copolymer models and suggests that similar types 
of defects may exist in mice that fail to produce suppression after GAT or GT 
immunization. A possible example of a GT factor-deficient mouse able to yield 
T~  when given  active  GT-TsF  is  the  A/J  mouse,  and  studies  are  currently 
underway to detect the reciprocal defect, in the hope that such mice will help 
map the cellular loci of action of the complementing  Is genes in the I-A or I-B 
and I-C subregions responsible for GT suppression. 
It should be noted, however, that acceptors for the I  region portion only of 
these various factors is not a  complete explanation for producer-acceptor cell 
interactions because the current work reveals a need for antigen as well in Ts 
induction. The role of this antigen may be to aid in focusing the T~F on the 
appropriate antigen-specific Ts precursor in high concentrations. The I  region 
acceptor could then  recognize the  T~F  and  trigger the  cell.  This  would be 
analogous to the model for specific B-cell  activation by low concentrations of 
haptenated polyclonal B-cell activators proposed by Coutinho and M611er (35). 
Conversely, a two-signal model can be proposed in which both antigen receptor 
binding and factor acceptor binding of their respective ligands is necessary for 
Ts  triggering.  The potential  roles of TsF  acceptors and antigen receptors in 
genetic  restriction  phenomena  and  Ts  triggering  can  now  be  explored  by 
sequential pulsing of lymphocytes with antigen and TsF, using the in vitro 
model detailed here. 
Summary 
A combination of in vitro and in vivo techniques were used to explore the 
mode of action of both crude and purified suppressive extracts specific for the 
random copolymer  L-giutamic acid6°-L-alanine3°-L-tyrosine  ~° (GAT-T~F)  obtained 
from nonresponder DBA/1  (H-2q) mice.  Normal DBA/1  spleen cells were in- 
cubated under modified Mishell-Dutton culture conditions for 2 days together 
with crude or purified GAT-TsF, and in the presence or absence of free GAT. 
These cells were then washed extensively and 3 ×  106 viable cells transferred 
to syngeneic recipients, which were challenged at the same time with the im- 
munogenic  form  of GAT  complexed to  methylated bovine  serum  albumin 
(GAT-MBSA). GAT-specific IgG plaque-forming cells (PFC) in the spleen were 
assayed 7 days later. In agreement with earlier in vitro studies on the action of 
GAT-T~F, it was demonstrated that under these conditions, low concentrations 
of GAT-T~F stimulated the development of cells which, aider transfer, are able 
to suppress the GAT PFC response to GAT-MBSA. The cells responsible for this 
suppression were shown to be T  lymphocytes by using nylon wool-purified T 
cells for suppressor cell induction and by eliminating suppressive activity in 
cells cultured with crude GAT-T~F by treatment with auti-Thy 1.2 plus C before 134  INDUCTION  OF  SUPPRESSOR  T  CELLS  IN  VITRO 
transfer.  The  suppressor  T  cells  act  in  a  specific manner failing to suppress 
significantly either anti-sheep erythrocyte or trinitrophenyl-ovalbumin primary 
PFC responses.  For the induction of GAT-specific suppressor T cells in culture, 
a moiety bearing H-2(Kq or Iq) determinants and also GAT, either bound to the 
crude GAT-TsF or added in nanogram amounts to antigen (GAT)-free purified 
GAT-TsF, were both required. 
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